1884: Code Brown

The provision is NDAA FY2027 §224 (House; renumbered §219 House / §1217 Senate): the 'United States–Israel Defense Technology Cooperation Initiative.' The bipartisan Khanna (D) + Massie (R) strike amendment was not ruled 'in order' — no debate, no floor vote.

<b>It is defense-INDUSTRIAL/tech cooperation — NOT a merger of the armed forces, not unified command, not a transfer of sovereignty. </b>Both sides agree: AIPAC — 'does not merge militaries… the Pentagon retains complete authority'; the critics (Quincy/Responsible Statecraft, Kim's own source) frame the harm narrowly as a preferential single-country procurement lane.

<b>The verbatim text undercuts even the 'no oversight' spin: </b>§224 never mentions DTSA and grants no override — the EA only 'coordinat[es]… to align efforts and avoid duplication'; it also REQUIRES protecting sensitive tech + national-security interests, consistency with existing law, a 180-day briefing, annual reports to Congress through 2030, and a public-transparency website.

SEC. 224 [Log 85464]. UNITED STATES–ISRAEL DEFENSE TECHNOLOGY COOPERATION INITIATIVE.

(a) ESTABLISHMENT.—The Secretary of Defense shall designate an executive agent, as such term is defined in Department of Defense Directive 5101.01 (relating to DoD Executive Agent, issued February 7, 2022), respon- sible for synchronizing cooperative efforts between the United States and Israel, to expand and accelerate bilat- eral defense technology research, development, testing, evaluation, integration, and industrial cooperation, by— (1) identifying jointly developed or Israeli-origin technologies with operational utility for potential in- tegration into United States systems and programs of record; (2) ensuring collaborative research initiatives involving government, private sector, and academic institutions in the United States and Israel, is done in a manner that protects sensitive technology and information and the national security interests of the United States and Israel; (3) facilitating the transition of technologies from research and development into procurement and acquisition pathways; (4) establishing frameworks for joint ventures, licensing agreements, and United States-based co- production or manufacturing partnerships with Israeli industry; (5) coordinating with relevant Department of Defense components, including the Irregular War- fare Technical Support Directorate, capability devel- opment and innovation divisions, the Under Sec- retary of Defense for Research and Engineering, the Defense Innovation Unit, the United States-Israel Operations Technology Working Group, the Defense Advanced Research Projects Agency, the Missile De- fense Agency, the United States Space Command, the military departments, and other Department of Defense entities, as appropriate, to align efforts and avoid duplication; and (6) promoting joint training exercises and infor- mation-sharing mechanisms to enhance operational readiness to deploy jointly developed technologies.

(b) COOPERATIVE EFFORTS.—The synchronized co- operative efforts under subsection (a) may be carried out through the following domains: (1) Counter-Unmanned Systems including aer- ial, maritime, and ground platforms. (2) Anti-tunneling and subterranean threats. (3) Missile and air defense technologies. (4) Artificial intelligence, quantum, machine learning, and autonomous systems. (5) Directed energy and advanced sensing. (6) Cyber defense, electronic warfare, and dig- ital resilience. (7) Biotechnology, biomanufacturing, and med- ical defense. (8) Network integration, data fusion, and con- tested logistics. (9) Defense industrial base cooperation, manu- facturing, and co-production. (10) Other emerging technologies as jointly agreed by the United States and Israel.

(c) ACTIVITIES IN COORDINATION WITH OTHER FEDERAL DEPARTMENTS AND AGENCIES.—The Sec- retary of Defense shall coordinate activities, as appro- priate, with the Secretary of State, the Secretary of Com- merce, and the heads of other relevant Federal depart- ments and agencies, to ensure consistency with existing laws and regulations.

(d) INTERIM PROGRESS UPDATE.—Not later than 180 days after the date of enactment of this Act, the Sec- retary of Defense shall provide to the congressional de- fense committees an interim briefing on— (1) the executive agent designated pursuant to subsection (a) and the efforts undertaken by such executive agent to lead Department of Defense im- plementation of the synchronized cooperative efforts described in such subsection; (2) the status of coordination, Department- wide, with Israeli counterparts; (3) initial technology areas identified for accel- erated cooperation and technologies with operational utility for integration into United States systems and programs of record; and (4) any early transition, prototyping, or integra- tion activities initiated during the period covered by the update.

(e) ANNUAL REPORT.—Not later than 1 year after the date of enactment of this Act, and annually thereafter until 2030, the Secretary of Defense shall submit to the congressional defense committees a report on implementa- tion of the cooperative efforts described in subsection (a). Each such report shall include— (1) a description of activities conducted; (2) an assessment of progress made in advanc- ing shared national security interests; (3) an assessment of collaboration with other relevant Federal programs; (4) a description of technologies transitioned into United States acquisition programs or fielded systems; (5) a description of partnerships established with United States and Israeli industry; and (6) recommendations for future opportunities to promote the long-term integration of joint capabili- ties between the United States and Israel.

(f) FORM.—Each report required under subsection

(e) shall be submitted in unclassified form and may in- clude a classified annex.

(g) PUBLIC TRANSPARENCY.—The Secretary of De- fense shall make available on a publicly accessible website of the Department of Defense periodic, unclassified up- dates, to the maximum extent practicable, on the syn- chronized cooperative efforts carried out under subsection (a), including a description of how these efforts contribute to United States technological and military supremacy. Such updates shall be made in a manner that ensures that classified information or other information that would compromise operational security, export controls, or sen- sitive technology are not released.

MSM frames TGA's cause as 'as mysterious as the brain itself' — but the WHO VigiBase safety database's disproportionality analysis (Frontiers in Pharmacology, 2022) found that of ALL transient-global-amnesia reports through Dec 2021, 289 were associated with a COVID-19 vaccine — the single MOST FREQUENT association.

Plus case reports of TGA within hours/days of the shot (65-yo post-3rd-dose; 44-yo post-Pfizer, workup negative).

<b>Not a claim about Couric: </b>she's 69; her own named triggers were altitude (Aspen ~8,000 ft), dehydration, stress. The beat is the GAP — 'mysterious cause' narrative vs the #1 reported association in the WHO database.